♥

SANDU PHARMACEUTICALS LTD

ISIN : INE751D01014
BSE : 524703
Face Value : 10
Industry : Pharmaceuticals & Drugs

EPS : 151.00
EPS (TTM) : 1.57
Price to Earning (P/E) : 0.21
Book Value : 31.47
Price to Bookvalue (P/B) : 1.03
Dividend Yield : 2 %
Return on Equity (ROE) : 5.00 %
Return on Capital Employed (ROCE) : 7.55 %

SANDU PHARMACEUTICALS share price (02-Apr-2026)
Bombay Stock Exchange BSE
Open / Close	33.55 - 32.42 -3.4 %
Low / High	32 - 33.55 4.8 %
Trade Volume	1,722
52 Week Low / High	30 - 58.8 96 %

YOU MAY ALSO LIKE

Stock market course tutorial
Stock Market Investment Course explained in simple words.
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Share Market basics for beginners
Share Market jargons in simple terms
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR SANDU PHARMACEUTICALS LTD

Date End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	months	months
Net Sales	167.64	170.92	152.65	176.57	166.07	174.29	155.98	170.45
Total Income	169.32	171.2	153.1	176.58	166.94	174.55	159.07	170.9
Total Expenditure	159.05	162.75	147.83	173.02	157.82	169.19	149.94	166.39
Other Income	1.69	0.28	0.45	0.01	0.87	0.27	3.09	0.45
Operating Profit	10.27	8.45	5.27	3.56	9.12	5.36	9.13	4.51
Interest	0.22	0.19	0.16	0.23	0.15	0.18	0.07	0.21
PBDT	10.05	8.26	5.11	3.33	8.97	5.18	9.06	4.3
Depreciation	1.29	1.29	1.34	1.22	1.33	1.42	1.86	1.59
Profit Before Tax	8.76	6.97	3.77	2.11	7.64	3.76	7.2	2.71
Tax	2.79	2.17	1.05	1.02	2.14	1.71	1.24	1.05
Profit After Tax	5.97	4.8	2.72	1.09	5.5	2.05	5.96	1.66
Net Profit	5.97	4.8	2.72	1.09	5.5	2.05	5.96	1.66
Equity Capital	96.61	96.61	96.61	96.61	96.61	96.61	96.61	96.61
Face Value (IN RS)	10	10	10	10	10	10	10	10
Calculated EPS	0.62	0.5	0.28	0.11	0.57	0.21	0.62	0.17
Diluted Eps After Extraordinary Items	0.64	0.51	0.26	0.11	0.57	0.21	0.62	0.17
Diluted Eps Before Extraordinary Items	0.64	0.51	0.26	0.11	0.57	0.21	0.62	0.17

STANDALONE QUARTERLY RESULT FOR SANDU PHARMACEUTICALS LTD

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	114.24	162.28	167.64	170.92	152.65	176.57	166.07	174.29	155.98	170.45
Total Income	114.52	163.14	169.32	171.2	153.1	176.58	166.94	174.55	159.04	170.9
Total Expenditure	108.49	159.01	159.03	162.73	147.82	173.02	157.81	169.18	149.94	166.39
Other Income	0.28	0.86	1.69	0.28	0.45	0.01	0.87	0.27	3.07	0.45
Operating Profit	6.03	4.13	10.29	8.47	5.28	3.56	9.13	5.37	9.1	4.51
Interest	0.21	0.23	0.22	0.19	0.16	0.23	0.15	0.18	0.07	0.21
PBDT	5.82	3.9	10.07	8.28	5.12	3.33	8.98	5.19	9.03	4.3
Depreciation	1.31	1.26	1.29	1.29	1.34	1.22	1.33	1.42	1.86	1.59
Profit Before Tax	4.51	2.64	8.78	6.99	3.78	2.11	7.65	3.77	7.17	2.71
Tax	1.8	0.95	2.79	2.17	1.04	1.01	2.14	1.71	1.24	1.04
Profit After Tax	2.71	1.69	5.99	4.82	2.74	1.1	5.51	2.06	5.93	1.67
Net Profit	2.71	1.69	5.99	4.82	2.74	1.1	5.51	2.06	5.93	1.67
Equity Capital	88.11	88.11	96.61	96.61	96.61	96.61	96.61	96.61	96.61	96.61
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	0.31	0.19	0.62	0.5	0.28	0.11	0.57	0.21	0.61	0.17
Diluted Eps After Extraordinary Items	0.31	0.18	0.64	0.52	0.27	0.11	0.57	0.21	0.5	0.17
Diluted Eps Before Extraordinary Items	0.31	0.18	0.64	0.52	0.27	0.11	0.57	0.21	0.5	0.17

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR SANDU PHARMACEUTICALS LTD

Date End	Mar 2023	Mar 2024
No of months	12 months	12 months	months
Net Sales	653.49	672.81
Total Income	656.76	677.04
Total Expenditure	628.63	649.86
Other Income	3.27	4.24
Operating Profit	28.13	27.18
Interest	0.8	0.63
PBDT	27.33	26.55
Depreciation	5.17	5.83
Profit Before Tax	22.16	20.72
Tax	6.97	6.12
Profit After Tax	15.19	14.6
Net Profit	15.19	14.6
Equity Capital	96.61	96.61
Face Value (IN RS)	10	10
Calculated EPS	1.57	1.51
Diluted Eps After Extraordinary Items	1.61	151
Diluted Eps Before Extraordinary Items	1.61	151

STANDALONE ANNUAL RESULT FOR SANDU PHARMACEUTICALS LTD

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	655	653.49	672.81
Total Income	655.83	656.76	677.02
Total Expenditure	626.26	628.6	649.84
Other Income	0.83	3.27	4.21
Operating Profit	29.57	28.16	27.18
Interest	1.1	0.8	0.63
PBDT	28.47	27.36	26.55
Depreciation	5.3	5.17	5.83
Profit Before Tax	23.17	22.19	20.72
Tax	7.27	6.97	6.12
Profit After Tax	15.9	15.22	14.6
Net Profit	15.9	15.22	14.6
Equity Capital	88.11	96.61	96.61
Face Value (IN RS)	10	10	10
Calculated EPS	1.8	1.58	1.51
Diluted Eps After Extraordinary Items	1.87	1.62	1.51
Diluted Eps Before Extraordinary Items	1.87	1.62	1.51

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2023
No of Months	12 months	months	months
Gross Sales	65.35 Cr	0	0
Sales	65.35 Cr	0	0
Net Sales	65.35 Cr	0	0
Increase/Decrease in Stock	-3.08 Cr	0	0
Raw Material Consumed	34.27 Cr	0	0
Opening Raw Materials	1.34 Cr	0	0
Purchases Raw Materials	11.11 Cr	0	0
Closing Raw Materials	1.32 Cr	0	0
Other Direct Purchases / Brought in cost	23.13 Cr	0	0
Power & Fuel Cost	39.02 Lk	0	0
Electricity & Power	39.02 Lk	0	0
Employee Cost	11.1 Cr	0	0
Salaries, Wages & Bonus	10.58 Cr	0	0
Contributions to EPF & Pension Funds	38.6 Lk	0	0
Workmen and Staff Welfare Expenses	7.9 Lk	0	0
Other Manufacturing Expenses	3.32 Cr	0	0
Repairs and Maintenance	2.09 Cr	0	0
General and Administration Expenses	6.91 Cr	0	0
Rent , Rates & Taxes	1.03 Cr	0	0
Insurance	6.12 Lk	0	0
Printing and stationery	37.17 Lk	0	0
Professional and legal fees	58.59 Lk	0	0
Traveling and conveyance	4.34 Cr	0	0
Selling and Distribution Expenses	9.71 Cr	0	0
Advertisement & Sales Promotion	5.66 Cr	0	0
Freight and Forwarding	4.06 Cr	0	0
Miscellaneous Expenses	24.64 Lk	0	0
Provision for doubtful debts	3.76 Lk	0	0
Total Expenditure	62.86 Cr	0	0
Other Income	32.72 Lk	0	0
Interest Received	15.8 Lk	0	0
Operating Profit	2.81 Cr	0	0
Interest	7.96 Lk	0	0
Intereston Fixed deposits	4.85 Lk	0	0
Bank Charges etc	75,000	0	0
PBDT	2.73 Cr	0	0
Depreciation	51.68 Lk	0	0
Profit Before Taxation & Exceptional Items	2.22 Cr	0	0
Profit Before Tax	2.22 Cr	0	0
Provision for Tax	69.62 Lk	0	0
Current Income Tax	62.85 Lk	0	0
Deferred Tax	3.38 Lk	0	0
Profit After Tax	1.52 Cr	0	0
Consolidated Net Profit	1.52 Cr	0	0
Profit Balance B/F	6.68 Cr	0	0
Appropriations	8.2 Cr	0	0
Other Appropriation	50.53 Lk	0	0
Equity Dividend %	7.5
Earnings Per Share	1.57
Adjusted EPS	1.57

STANDALONE PROFIT / LOSS FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023
No of Months	12 months	12 months	12 months
Gross Sales	58.76 Cr	75.46 Cr	65.35 Cr
Sales	58.72 Cr	75.46 Cr	65.35 Cr
Net Sales	58.76 Cr	65.5 Cr	65.35 Cr
Increase/Decrease in Stock	3.39 Cr	-45.43 Lk	-3.08 Cr
Raw Material Consumed	31.11 Cr	36.2 Cr	34.27 Cr
Opening Raw Materials	1.5 Cr	1.66 Cr	1.34 Cr
Purchases Raw Materials	12.04 Cr	13.88 Cr	11.11 Cr
Closing Raw Materials	1.66 Cr	1.34 Cr	1.32 Cr
Other Direct Purchases / Brought in cost	19.24 Cr	22 Cr	23.13 Cr
Power & Fuel Cost	32.68 Lk	34.25 Lk	39.02 Lk
Electricity & Power	32.68 Lk	34.25 Lk	39.02 Lk
Employee Cost	8.02 Cr	8.91 Cr	11.1 Cr
Salaries, Wages & Bonus	7.5 Cr	8.24 Cr	10.58 Cr
Contributions to EPF & Pension Funds	26.5 Lk	33.52 Lk	38.6 Lk
Workmen and Staff Welfare Expenses	21.21 Lk	29.95 Lk	7.9 Lk
Other Manufacturing Expenses	3.17 Cr	3.76 Cr	3.32 Cr
Repairs and Maintenance	1.84 Cr	2.09 Cr	2.09 Cr
General and Administration Expenses	3.45 Cr	5.16 Cr	6.9 Cr
Rent , Rates & Taxes	35.17 Lk	34.29 Lk	1.03 Cr
Insurance	10.56 Lk	13.19 Lk	6.12 Lk
Printing and stationery	9.31 Lk	18.11 Lk	37.17 Lk
Professional and legal fees	38.8 Lk	63.69 Lk	58.26 Lk
Traveling and conveyance	2.07 Cr	3.39 Cr	4.34 Cr
Selling and Distribution Expenses	6.9 Cr	8.51 Cr	9.71 Cr
Advertisement & Sales Promotion	3.56 Cr	4.74 Cr	5.66 Cr
Freight and Forwarding	3.34 Cr	3.77 Cr	4.06 Cr
Miscellaneous Expenses	23.67 Lk	19.3 Lk	24.63 Lk
Provision for doubtful debts	0	3.96 Lk	3.76 Lk
Total Expenditure	56.6 Cr	62.63 Cr	62.86 Cr
Other Income	19.34 Lk	8.27 Lk	32.72 Lk
Interest Received	18.89 Lk	7.63 Lk	15.8 Lk
Dividend Received	45,718	60,000	0
Operating Profit	2.35 Cr	2.96 Cr	2.82 Cr
Interest	11.49 Lk	11 Lk	7.96 Lk
Intereston Fixed deposits	3.52 Lk	4.08 Lk	4.85 Lk
Bank Charges etc	5.03 Lk	3.61 Lk	75,000
PBDT	2.24 Cr	2.85 Cr	2.74 Cr
Depreciation	55.67 Lk	53.01 Lk	51.68 Lk
Profit Before Taxation & Exceptional Items	1.68 Cr	2.32 Cr	2.22 Cr
Profit Before Tax	1.68 Cr	2.32 Cr	2.22 Cr
Provision for Tax	58.84 Lk	72.74 Lk	69.62 Lk
Current Income Tax	55.71 Lk	69.59 Lk	62.85 Lk
Deferred Tax	2.95 Lk	3.15 Lk	3.38 Lk
Profit After Tax	1.09 Cr	1.59 Cr	1.52 Cr
Consolidated Net Profit	1.09 Cr	1.59 Cr	1.52 Cr
Profit Balance B/F	3.27 Cr	4.97 Cr	6.68 Cr
Appropriations	4.36 Cr	6.56 Cr	8.2 Cr
Other Appropriation	-60.88 Lk	-11.41 Lk	50.53 Lk
Equity Dividend %	5	7.5	7.5
Earnings Per Share	1.38	1.8	1.58
Adjusted EPS	1.38	1.8	1.58

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR SANDU PHARMACEUTICALS LTD

Year End	Mar 2023
No of Months	12 months	months	months
Profit Before Tax	2.22 Cr	0	0
Adjustment	47.8 Lk	0	0
Changes In working Capital	-1.77 Cr	0	0
Cash Flow after changes in Working Capital	92.05 Lk	0	0
Cash Flow from Operating Activities	22.11 Lk	0	0
Cash Flow from Investing Activities	53.67 Lk	0	0
Cash Flow from Financing Activitie	57.91 Lk	0	0
Net Cash Inflow / Outflow	1.34 Cr	0	0
Opening Cash & Cash Equivalents	93.86 Lk	0	0
Closing Cash & Cash Equivalent	2.28 Cr	0	0

STANDALONE CASH FLOW FOR SANDU PHARMACEUTICALS LTD

Year End	Mar 2021	Mar 2022	Mar 2023
No of Months	12 months	12 months	12 months
Profit Before Tax	1.68 Cr	2.32 Cr	2.22 Cr
Adjustment	62.25 Lk	63.36 Lk	47.8 Lk
Changes In working Capital	5.75 Cr	-1.12 Cr	-1.78 Cr
Cash Flow after changes in Working Capital	8.05 Cr	1.83 Cr	92.06 Lk
Cash Flow from Operating Activities	7.59 Cr	94.87 Lk	22.12 Lk
Cash Flow from Investing Activities	-5.58 Cr	-5.47 Cr	52.66 Lk
Cash Flow from Financing Activitie	1.3 Cr	93.43 Lk	57.91 Lk
Net Cash Inflow / Outflow	3.31 Cr	-3.59 Cr	1.33 Cr
Opening Cash & Cash Equivalents	1.22 Cr	4.53 Cr	93.86 Lk
Closing Cash & Cash Equivalent	4.53 Cr	93.86 Lk	2.27 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2023
Share Capital	9.66 Cr	0	0
Equity - Authorised	10 Cr	0	0
Equity - Issued	9.66 Cr	0	0
Equity Paid Up	9.66 Cr	0	0
Face Value	10
Total Reserves	29.58 Cr	0	0
Securities Premium	2.76 Cr	0	0
Profit & Loss Account Balance	7.69 Cr	0	0
General Reserves	9.5 Cr	0	0
Reserve excluding Revaluation Reserve	20.74 Cr	0	0
Revaluation reserve	8.84 Cr	0	0
Shareholder's Funds	39.24 Cr	0	0
Deferred Tax Assets / Liabilities	1.04 Cr	0	0
Deferred Tax Assets	1.35 Lk	0	0
Deferred Tax Liability	1.06 Cr	0	0
Total Non-Current Liabilities	1.04 Cr	0	0
Trade Payables	8.4 Cr	0	0
Sundry Creditors	8.4 Cr	0	0
Other Current Liabilities	1.41 Cr	0	0
Advances received from customers	39.24 Lk	0	0
Short Term Provisions	4.08 Cr	0	0
Provision for Tax	1.32 Cr	0	0
Provision for post retirement benefits	1.47 Cr	0	0
Total Current Liabilities	13.88 Cr	0	0
Total Liabilities	54.17 Cr	0	0
Gross Block	27.51 Cr	0	0
Less: Accumulated Depreciation	10.89 Cr	0	0
Net Block	16.62 Cr	0	0
Capital Work in Progress	41.96 Lk	0	0
Non Current Investments	9.65 Cr	0	0
Long Term Investment	9.65 Cr	0	0
Quoted	9.65 Cr	0	0
Unquoted	10,000	0	0
Other Non Current Assets	1.94 Cr	0	0
Total Non-Current Assets	28.62 Cr	0	0
Unquoted	10,000	0	0
Inventories	14.33 Cr	0	0
Raw Materials	1.32 Cr	0	0
Work-in Progress	1.36 Cr	0	0
Finished Goods	4.13 Cr	0	0
Sundry Debtors	4.79 Cr	0	0
Debtors more than Six months	1.37 Cr	0	0
Debtors Others	3.48 Cr	0	0
Cash and Bank	2.3 Cr	0	0
Cash in hand	3.6 Lk	0	0
Balances at Bank	2.26 Cr	0	0
Other Current Assets	39.32 Lk	0	0
Interest accrued on Investments	14.01 Lk	0	0
Prepaid Expenses	7.61 Lk	0	0
Short Term Loans and Advances	3.74 Cr	0	0
Advances recoverable in cash or in kind	82.8 Lk	0	0
Total Current Assets	25.55 Cr	0	0
Net Current Assets (Including Current Investments)	11.66 Cr	0	0
Total Assets	54.17 Cr	0	0
Contingent Liabilities	3.37 Cr	0	0
Adjusted Book Value	31.47

STANDALONE BALANCE SHEET FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023
Share Capital	7.92 Cr	8.81 Cr	9.66 Cr
Equity - Authorised	10 Cr	10 Cr	10 Cr
Equity - Issued	7.92 Cr	8.81 Cr	9.66 Cr
Equity Paid Up	7.92 Cr	8.81 Cr	9.66 Cr
Face Value	10	10	10
Total Reserves	24.67 Cr	27.22 Cr	29.58 Cr
Securities Premium	89.8 Lk	1.85 Cr	2.76 Cr
Profit & Loss Account Balance	4.97 Cr	6.68 Cr	7.7 Cr
General Reserves	9.5 Cr	9.5 Cr	9.5 Cr
Reserve excluding Revaluation Reserve	15.55 Cr	18.24 Cr	20.74 Cr
Revaluation reserve	9.12 Cr	8.98 Cr	8.84 Cr
Shareholder's Funds	33.49 Cr	36.47 Cr	39.24 Cr
Deferred Tax Assets / Liabilities	95.27 Lk	93.65 Lk	1.04 Cr
Deferred Tax Assets	3.92 Lk	1.72 Lk	1.35 Lk
Deferred Tax Liability	99.18 Lk	95.37 Lk	1.06 Cr
Total Non-Current Liabilities	95.27 Lk	93.65 Lk	1.04 Cr
Trade Payables	6.67 Cr	6.82 Cr	8.4 Cr
Sundry Creditors	6.67 Cr	6.82 Cr	8.4 Cr
Other Current Liabilities	1.1 Cr	1.2 Cr	1.41 Cr
Advances received from customers	14.79 Lk	15.48 Lk	39.24 Lk
Short Term Borrowings	1.93 Lk	0	0
Secured ST Loans repayable on Demands	1.93 Lk	0	0
Working Capital Loans- Sec	1.93 Lk	0	0
Short Term Provisions	4.73 Cr	3.85 Cr	4.07 Cr
Provision for Tax	83.21 Lk	1.53 Cr	1.32 Cr
Provision for post retirement benefits	0	1.18 Cr	1.47 Cr
Total Current Liabilities	12.52 Cr	11.87 Cr	13.88 Cr
Total Liabilities	46.96 Cr	49.28 Cr	54.17 Cr
Gross Block	26.02 Cr	26.38 Cr	27.51 Cr
Less: Accumulated Depreciation	9.84 Cr	10.37 Cr	10.89 Cr
Net Block	16.17 Cr	16 Cr	16.62 Cr
Capital Work in Progress	0	48.18 Lk	41.96 Lk
Non Current Investments	24.17 Lk	9.11 Cr	9.66 Cr
Long Term Investment	24.17 Lk	9.11 Cr	9.66 Cr
Quoted	24.07 Lk	9.11 Cr	9.65 Cr
Unquoted	10,000	10,000	1.1 Lk
Other Non Current Assets	43,433	4.63 Lk	1.94 Cr
Total Non-Current Assets	16.42 Cr	25.64 Cr	28.63 Cr
Unquoted	10,000	10,000	1.1 Lk
Inventories	11.14 Cr	11.27 Cr	14.33 Cr
Raw Materials	1.66 Cr	1.34 Cr	1.32 Cr
Work-in Progress	29.1 Lk	57.19 Lk	1.36 Cr
Finished Goods	2.99 Cr	3.6 Cr	4.13 Cr
Sundry Debtors	5.35 Cr	3.99 Cr	4.79 Cr
Debtors more than Six months	0	50.5 Lk	1.37 Cr
Debtors Others	5.47 Cr	3.55 Cr	3.48 Cr
Cash and Bank	11.66 Cr	4.17 Cr	2.29 Cr
Cash in hand	20.06 Lk	8.63 Lk	3.6 Lk
Balances at Bank	11.46 Cr	4.08 Cr	2.25 Cr
Other Current Assets	30.52 Lk	51.56 Lk	39.32 Lk
Interest accrued on Investments	12.4 Lk	3.43 Lk	14.01 Lk
Prepaid Expenses	18.11 Lk	8.74 Lk	7.61 Lk
Short Term Loans and Advances	2.1 Cr	3.7 Cr	3.74 Cr
Advances recoverable in cash or in kind	14.81 Lk	26.45 Lk	82.8 Lk
Total Current Assets	30.54 Cr	23.65 Cr	25.54 Cr
Net Current Assets (Including Current Investments)	18.02 Cr	11.77 Cr	11.66 Cr
Total Assets	46.96 Cr	49.28 Cr	54.17 Cr
Contingent Liabilities	2.83 Cr	2.83 Cr	3.37 Cr
Total Debt	1.93 Lk	0	0
Book Value	29.63	30.71	0
Adjusted Book Value	29.63	30.71	31.47

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2023
Operational & Financial Ratios
Earnings Per Share (Rs)	1.57
CEPS(Rs)	2.11
DPS(Rs)	0.75
Book NAV/Share(Rs)	31.47
Tax Rate(%)	31.41
Margin Ratios
Core EBITDA Margin(%)	3.8
EBIT Margin(%)	3.51
Pre Tax Margin(%)	3.39
PAT Margin (%)	2.33
Cash Profit Margin (%)	3.12
Performance Ratios
ROA(%)	2.81
ROE(%)	5
ROCE(%)	7.55
Asset Turnover(x)	1.21
Sales/Fixed Asset(x)	2.38
Working Capital/Sales(x)	5.6
Efficiency Ratios
Fixed Capital/Sales(x)	0.42
Receivable days	26.77
Inventory Days	80.01
Payable days	98.27
Valuation Parameters
PER(x)	33.17
PCE(x)	24.75
Price/Book(x)	1.66
Yield(%)	1.44
EV/Net Sales(x)	0.74
EV/Core EBITDA(x)	17.11
EV/EBIT(x)	20.96
EV/CE(x)	0.89
M Cap / Sales	0.77
Growth Ratio
Financial Stability Ratios
Current Ratio(x)	1.84
Quick Ratio(x)	0.81
Interest Cover(x)	28.85

FINANCIAL RATIOS (STANDALONE) FOR SANDU PHARMACEUTICALS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023
Operational & Financial Ratios
Earnings Per Share (Rs)	1.38	1.8	1.58
CEPS(Rs)	2.08	2.41	2.11
DPS(Rs)	0.5	0.75	0.75
Book NAV/Share(Rs)	29.63	30.71	31.47
Tax Rate(%)	35.01	31.4	31.36
Margin Ratios
Core EBITDA Margin(%)	3.67	3.81	3.81
EBIT Margin(%)	3.06	3.22	3.52
Pre Tax Margin(%)	2.86	3.07	3.4
PAT Margin (%)	1.86	2.11	2.33
Cash Profit Margin (%)	2.81	2.81	3.12
Performance Ratios
ROA(%)	2.47	3.3	2.95
ROE(%)	5.03	6.29	5.3
ROCE(%)	7.87	9.35	7.94
Asset Turnover(x)	1.33	1.57	1.26
Sales/Fixed Asset(x)	2.26	2.88	2.43
Working Capital/Sales(x)	3.26	6.41	5.61
Efficiency Ratios
Fixed Capital/Sales(x)	0.44	0.35	0.41
Receivable days	31.15	22.59	24.53
Inventory Days	79.2	54.2	71.49
Payable days	65.75	68.87	89.03
Valuation Parameters
PER(x)	23.17	39	33.09
PCE(x)	15.35	29.25	24.71
Price/Book(x)	1.08	2.29	1.66
Yield(%)	1.56	1.07	1.44
EV/Net Sales(x)	0.23	0.88	0.74
EV/Core EBITDA(x)	5.81	19.55	17.09
EV/EBIT(x)	7.61	23.82	20.94
EV/CE(x)	0.29	1.17	0.89
M Cap / Sales	0.43	0.95	0.77
Growth Ratio
Net Sales Growth(%)	21.28	11.48	-0.23
Core EBITDA Growth(%)	23.28	25.68	-4.74
EBIT Growth(%)	32.65	35.12	-5.23
PAT Growth(%)	51.67	45.47	-4.12
EPS Growth(%)	35.58	30.78	-12.55
Financial Stability Ratios
Current Ratio(x)	2.44	1.99	1.84
Quick Ratio(x)	1.55	1.04	0.81
Interest Cover(x)	15.62	22.06	28.89

SHARE HOLDING PATTERN FOR SANDU PHARMACEUTICALS LTD

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	50.43	49.47	49.47	51.53	52.41	52.41	42.90	42.90	42.90	42.90
FII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public %	49.56	50.52	50.52	48.46	47.58	47.58	57.09	57.09	57.09	57.09

PEER COMPARISON FOR SANDU PHARMACEUTICALS LTD

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR SANDU PHARMACEUTICALS

Exchange Date	Purpose	Book Closure Dates
BSE 19-Sep-2024	Dividend - Rs.0.8000 per share(8%)Final Dividend
BSE 14-Aug-2024	Book Closure - Rs.0.8000 per share(8%)Final Dividend & A.G.M.	20-Sep-2024 30-Sep-2024
BSE 14-Aug-2024	AGM - Rs.0.8000 per share(8%)Final Dividend & A.G.M.	30-Sep-2024 30-Sep-2024
BSE 05-Aug-2024	Board Meeting - Quarterly Results & Final Dividend	12-Aug-2024
BSE 31-May-2024	Board Meeting - Audited Results (Revised)	05-Jun-2024
BSE 21-May-2024	Board Meeting - Audited Results	30-May-2024
BSE 20-Mar-2024	Board Meeting - Inter alia, to consider and approve: - 1. To Consider and Appoint Chief Financial Officer of the Company. 2. Any other matter with the permission of Chairman.	30-Mar-2024
BSE 05-Feb-2024	Board Meeting - Quarterly Results	14-Feb-2024
BSE 03-Nov-2023	Board Meeting - Quarterly Results	13-Nov-2023
BSE 18-Sep-2023	Dividend - Rs.0.7500 per share(7.5%)Final Dividend
BSE 14-Aug-2023	Book Closure - Rs.0.7500 per share(7.5%)Final Dividend & A.G.M.	20-Sep-2023 30-Sep-2023
BSE 14-Aug-2023	AGM - Rs.0.7500 per share(7.5%)Final Dividend & A.G.M.	30-Sep-2023 30-Sep-2023
BSE 04-Aug-2023	Board Meeting - Quarterly Results & Final Dividend	14-Aug-2023
BSE 23-May-2023	Board Meeting - Audited Results	30-May-2023
BSE 03-Feb-2023	Board Meeting - Quarterly Results	14-Feb-2023
BSE 01-Nov-2022	Board Meeting - Quarterly Results	14-Nov-2022
BSE 16-Aug-2022	Book Closure - A.G.M. & Dividend	24-Sep-2022 30-Sep-2022
BSE 16-Aug-2022	AGM - A.G.M. & Dividend	30-Sep-2022 30-Sep-2022
BSE 12-Aug-2022	Dividend - Rs.0.0750 per share(0.75%)Dividend
BSE 01-Aug-2022	Board Meeting - Quarterly Results & Dividend	12-Aug-2022
BSE 04-Jul-2022	Board Meeting - Inter alia, to consider and approve : 1. To Consider and Reappoint CMA Shekhar Joshi & Co, Cost Accountants (Registration No. 100448) as Cost Auditor of the Company for the Financial Year 2022-23. 2. To Consider/Approve/Discuss on 03RD and Final Tranche, conversion of 8,50,326 nos of Equity Warrants Conversion into Equity Shares. 3. Any other matter.	07-Jul-2022
BSE 16-May-2022	Board Meeting - Audited Results	30-May-2022
BSE 07-Feb-2022	Board Meeting - Quarterly Results	14-Feb-2022
BSE 25-Nov-2021	Board Meeting - Inter alia, to consider and approve Appointment of Internal Auditor for Mumbai at its Corporate Office	29-Nov-2021
BSE 01-Nov-2021	Board Meeting - Quarterly Results	13-Nov-2021

CORPORATE ANNOUNCEMENTS FOR SANDU PHARMACEUTICALS

Exchange Date	Category File	Description
BSE 30-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Duplicate issue of share certificate
BSE 16-Oct-2024	General Announcements FILE	Notice For Intimating Discrepancies In The Return After Scrutiny For The Financial Year 2020-2021 Under Section 61 Of CGST ACT 2017 Notice for intimating discrepancies in the return after scrutiny for the FY 2020-21 under section 61 of CGST Act 2017
BSE 08-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Stop Transfer for duplicate issue of Share Certificate
BSE 08-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Reg 74(5) of SEBI (DP) regulation for Q ended 30th September 2024
BSE 01-Oct-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Scrutinizers Report and Voting Results of Sandu Pharmaceuticals Limited 39th Annual General Meeting held on 30th September 2024
BSE 30-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate 1.Appointment of Vijay Kottapalli (DIN:10245156) as Non Executive Independent Director2.Appointment of Smt Jayshree Bhasker Sandu(DIN:07480177) as Non Executive Non Independent Women Director of the company who is above 75 years of age
BSE 30-Sep-2024	General Announcements FILE	Disclosure Of Events Or Information Under Regulation 30 Of SEBI (LODR)Regulation Pertaining To 39" Annual General Meeting Held On Monday 30TSeptember 2024 At 04:30 Pm With Scrip Code 524703. Disclosure of events or information Under Regulation 30 of LODR
BSE 30-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of the 39th Annual General Meeting
BSE 23-Sep-2024	Intimation FILE	Closure of Trading Window Closure of Trading Window for Q ended 30th September 2024
BSE 21-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate stop transfer for duplicate issue of share certificate
BSE 14-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Reg 39(3) stop transfer for duplicate issue of share certificate
BSE 07-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement Notice of Annual general Meeting and E-votiing Instructions -Regional Language
BSE 06-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication inrespect of the Notice of the AGM
BSE 05-Sep-2024	General Announcements FILE	Reg. 34 (1) Annual Report. 39th Annual Report of Sandu Pharmaceuticals Limited
BSE 05-Sep-2024	Intimation FILE	Notice Of The 39Th Annual General Meeting Notice of the 39th Annual General Meeting to be Held on Monday 30th September 2024.
BSE 05-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Duplicate issue of Share Certificate
BSE 31-Aug-2024	General Announcements FILE	Announcement Under Regulation 30-Newspaper Publication copy of the newspaper Advertisement under Regulation 47 of SEBI(LODR)-Notice to shareholders
BSE 21-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Stop transfer for duplicate issue of share certificate
BSE 14-Aug-2024	General Announcements FILE	Newspaper Publication In Respect Of Unaudited Financials For Q Ended 30Th June 2024 Newspaper Publication in respect of Unaudited Financials for Q ended 30th June 2024
BSE 12-Aug-2024	General Announcements FILE	Intimation Of The Date Of The 39Th Annual General Meeting Intimation of the date of the Annual General Meeting
BSE 12-Aug-2024	Outcome FILE	Corporate Action-Board approves Dividend Board Has approved Dividend Payable subjected to approval of shareholders
BSE 12-Aug-2024	Intimation FILE	Intimation Of Record Date For Dividend Intimation of Record Date for Dividend
BSE 12-Aug-2024	Intimation FILE	Intimation About Book Closure Intimation about Book closure for Annual General Meeting
BSE 12-Aug-2024	Intimation FILE	Intimation About Book Closure Intimation about Book closure for Annual General Meeting
BSE 12-Aug-2024	General Announcements FILE	Disclosure Under Regulation 30 Disclosure under Regulation 30
BSE 12-Aug-2024	Compliance FILE	Statement Of Deviation And Variation For The Q Ended 30Th June 2024 Statement of deviation and variation for the q ended 30th June 2024
BSE 12-Aug-2024	General Announcements FILE	Intimation Of Comments Made By Board Of Directors On Non-Compliance With Delayed Submission Of Financials For Year Ended 31St March 2024 Intimation of Comments made by board on non compliance with delayed submission of Financials for year ended 31.03.2024
BSE 12-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate change in directorate
BSE 12-Aug-2024	Outcome FILE	Unaudited Financial Results For Q Ended 30Th June 2024 Unaudited Financial Results for Q ended 30th June 2024
BSE 12-Aug-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting Outcome of the Board Meeting dated 12th August 2024

INSIDER TRADING FOR SANDU PHARMACEUTICALS

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 02-Mar-2022 02-Mar-2022	Buy Allotment	236,500 @ 0.00 (1.54 %)	SHASHANK B SANDU
BSE 02-Mar-2022 02-Mar-2022	Buy Allotment	236,500 @ 0.00 (1.52 %)	UMESH B SANDU
BSE 02-Mar-2022 02-Mar-2022	Buy Allotment	166,667 @ 0.00 (1.66 %)	AKSHATH FINVEST AND PROPERTIES PVT LTD

BULK BLOCK DEALS FOR SANDU PHARMACEUTICALS LTD

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 19-Mar-2024	Sell BULK	104,061 @ 55.85	DPS TRADELINK PRIVATE LIMITED
BSE 19-Mar-2024	Buy BULK	106,000 @ 55.88	TRANS SCAN SECURITIES PVT LTD

DIVIDEND BY SANDU PHARMACEUTICALS LTD

Ex Dividend Date	Dividend Type	Dividend
19-Sep-2024	DIVIDEND	0.8
18-Sep-2023	DIVIDEND	0.75
23-Sep-2022	DIVIDEND	0.75
22-Sep-2021	DIVIDEND	0.5

SPLIT / BONUS BY SANDU PHARMACEUTICALS LTD

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

SANDU PHARMACEUTICALS LTD

SANDU PHARMACEUTICALS share price

CONSOLIDATED QUARTERLY RESULT FOR SANDU PHARMACEUTICALS LTD

STANDALONE QUARTERLY RESULT FOR SANDU PHARMACEUTICALS LTD

CONSOLIDATED ANNUAL RESULT FOR SANDU PHARMACEUTICALS LTD

STANDALONE ANNUAL RESULT FOR SANDU PHARMACEUTICALS LTD

CONSOLIDATED PROFIT / LOSS FOR SANDU PHARMACEUTICALS LTD

STANDALONE PROFIT / LOSS FOR SANDU PHARMACEUTICALS LTD

CONSOLIDATED CASH FLOW FOR SANDU PHARMACEUTICALS LTD

STANDALONE CASH FLOW FOR SANDU PHARMACEUTICALS LTD

CONSOLIDATED BALANCE SHEET FOR SANDU PHARMACEUTICALS LTD

STANDALONE BALANCE SHEET FOR SANDU PHARMACEUTICALS LTD

FINANCIAL RATIOS (CONSOLIDATED) FOR SANDU PHARMACEUTICALS LTD

FINANCIAL RATIOS (STANDALONE) FOR SANDU PHARMACEUTICALS LTD

SHARE HOLDING PATTERN FOR SANDU PHARMACEUTICALS LTD

PEER COMPARISON FOR SANDU PHARMACEUTICALS LTD

CORPORATE ACTIONS FOR SANDU PHARMACEUTICALS

CORPORATE ANNOUNCEMENTS FOR SANDU PHARMACEUTICALS

INSIDER TRADING FOR SANDU PHARMACEUTICALS

BULK BLOCK DEALS FOR SANDU PHARMACEUTICALS LTD

DIVIDEND BY SANDU PHARMACEUTICALS LTD

SPLIT / BONUS BY SANDU PHARMACEUTICALS LTD